top of page
Accunea Logo - revolutionizing Kidney Transplant Monitoring with Microfluidics Innovaion Hub.
Open Call Project
Accunea's Kidney Viability Monitoring Device

Revolutionizing Kidney Transplants with Real-Time Monitoring

Accunea has developed a groundbreaking device for real-time monitoring of kidney viability in transplant procedures. This innovation leverages advanced microfluidics and sensor technology to provide critical data on organ health, addressing the pressing need for objective assessment tools in kidney transplantation.


Accunea’s device integrates microfluidics with cutting-edge electrochemical sensors to measure vital biomarkers in real time. These measurements offer unprecedented insights into the health of kidneys from deceased donors, facilitating better decision-making during transplants. The device is designed to be user-friendly, fitting seamlessly into existing medical workflows, and provides immediate, objective data to transplant surgeons.


The collaboration with MIH has brought together experts in microfluidics, sensor technology, and system integration, ensuring that the device meets the highest standards of performance and reliability. By improving the assessment process for donor kidneys, this technology aims to increase the utilization of viable organs, thus addressing the critical shortage of available kidneys for transplantation.

Accunea's Kidney Transplants Innovation

Accunea has approached MIH to develop a device that can objectively monitor the viability of kidneys from deceased donors, using real-time data to improve transplant outcomes.

Send us your inquiry today to join the forefront of transplant technology!

Image of Accunea's Kidney Transplants Innovation - microfluidic detection.
Goal

Develop a real-time monitoring device for kidney viability;
Provide objective data for transplant decisions;
Ensure compatibility with existing medical equipment;

Solution

Technical Management: Oversight of microfluidic cartridge design, ensuring efficient processing of biological fluids.
Sensor Development: Creation of high-sensitivity electrochemical sensors for real-time monitoring.
Fluidic-Sensor Interface Simulation: Computational simulations to optimize sensor placement and performance.
Adapter Design and Testing: Development of adapters to ensure compatibility with medical equipment.

Requirements

Integration of microfluidics, sensor technology, and data analysis;
High sensitivity and specificity in biomarker detection;
Seamless integration with current medical setups;

The Role of the #MIHfamily

  • Microfluidics Innovation Hub (MIH) provides overarching project management and coordination, ensuring all partners work cohesively towards the project goals.

  • BiFlow Systems GmbH handles the design and manufacturing of the microfluidic cartridge.

  • Micronit develops the microfluidic adapters to ensure compatibility with existing equipment.

  • Joanneum Research conducts simulations to optimize the fluidic-sensor interface.

  • Jobst Technologies focuses on the development of high-performance electrochemical sensors.

Partners Involved

Add a Testimonial QuoteTextAdd a Testimonial QuoteText

Author

Injection Molding

Design and Simulation

Electrodes and Sensor

Get more Insights

Take a closer look on how Accunea revolutionizes kidney transplant monitoring with microfluidc help.

Revolutionizing Kidney Transplants: The Accunea Breakthrough

Revolutionizing Kidney Transplants: The Accunea Breakthrough

Revolutionizing Von Willebrand Disease Diagnosis: Technoclone's Innovative Microfluidic Solution

Revolutionizing Von Willebrand Disease Diagnosis: Technoclone's Innovative Microfluidic Solution

FluIDect's Microfluidic Technology: Revolutionizing Industrial Microbial Detection

FluIDect's Microfluidic Technology: Revolutionizing Industrial Microbial Detection

LUMICKS: Advancing Single-Molecule Research with Dynamic Microfluidic Solutions

LUMICKS: Advancing Single-Molecule Research with Dynamic Microfluidic Solutions

Enzyre's Chemiluminescent Microfluidic Platform: A New Era in Personalized Diagnostics

Enzyre's Chemiluminescent Microfluidic Platform: A New Era in Personalized Diagnostics

AcouSome Exosome Diagnostics

AcouSome Exosome Diagnostics

Revolutionizing Antibody Discovery: VERAXA Biotech's Microfluidic Marvel

Revolutionizing Antibody Discovery: VERAXA Biotech's Microfluidic Marvel

NGM Open Call: Revolutionizing Bacterial Detection - SensipDx Lab-on-a-Cartridge Technology

NGM Open Call: Revolutionizing Bacterial Detection - SensipDx Lab-on-a-Cartridge Technology

Microfluidics-Enhanced Circulating Tumor Cell Separation Towards Liquid Biopsy Cancer Diagnostics

Microfluidics-Enhanced Circulating Tumor Cell Separation Towards Liquid Biopsy Cancer Diagnostics

Revolutionizing Anemia Detection: Microfluidics in Point-of-Care Diagnostics

Revolutionizing Anemia Detection: Microfluidics in Point-of-Care Diagnostics

Prognostic Healthcare Innovation:  Multiplex Detection of Inflammatory Biomarkers for Patient Triage

Prognostic Healthcare Innovation: Multiplex Detection of Inflammatory Biomarkers for Patient Triage

Reference Case: PoC Test to Improve Diagnosis & Disease Monitoring of Chronic Kidney Diseases

Reference Case: PoC Test to Improve Diagnosis & Disease Monitoring of Chronic Kidney Diseases

Services and Technologies

The #MIHfamily, including leading experts from BiFlow Systems GmbH, Micronit, Joanneum Research, and Jobst Technologies (external partner) plays a crucial role in this endeavor. Their collective expertise in microfluidics, sensor development, and system integration is instrumental in bringing Accunea's vision to life.

This project has received funding from the European Union’s HORIZON 2020 research & innovation programme under grant agreement no. 862092.

bottom of page